Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan;7(1):36-47.
doi: 10.21037/tp.2017.08.02.

Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: a review for practitioners

Kelly A Brown  1 , Sharmeen Samuel  1 , Dilip R Patel  1
Affiliations
Review

Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: a review for practitioners

Kelly A Brown et al. Transl Pediatr. 2018 Jan.

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioral disorder in children and adolescents. ADHD affects multiple aspects of an individual's life and functioning in family, social, and academic realms. Effective management of ADHD is necessary for children and adolescents and may include non-pharmacologic treatments, pharmacologic therapy including use of stimulant and non-stimulant medications, or a combination of the different treatment modalities. In general, medications used to treat ADHD are safe and effective. Medical practitioners can follow a step-wise approach in the selection and adjustment of pharmacologic agents to treat ADHD, while working closely with families, caregivers, and other medical and educational professionals to form appropriate treatment plans. This article reviews practical aspects of pharmacological treatment of ADHD in children and adolescents.

Keywords: Attention-deficit/hyperactivity disorder (ADHD); alpha-2-agonists; amphetamine; methylphenidate; non-stimulant medication; stimulants.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Subcommittee on Attention-Deficit/Hyperactivity Disorder ; Steering Committee on Quality Improvement and Management, Wolraich M, et al. ADHD: clinical practice guideline for the diagnosis, evaluati on, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 2011;128:1007-22. 10.1542/peds.2011-2654 - DOI - PMC - PubMed
    1. Charach A, Dashti B, Carson P, et al. Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers; Long-Term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment. Available online: https://www.effectivehealthcare.ahrq.gov/ehc/products/191/818/CER44-ADHD... - PubMed
    1. Visser SN, Danielson ML, Bitsko RH, et al. Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011. J Am Acad Child Adolesc Psychiatry 2014;53:34–46.e2. 10.1016/j.jaac.2013.09.001 - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention (CDC) Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children --- United States, 2003 and 2007. MMWR Morb Mortal Wkly Rep 2010;59:1439-43. - PubMed
    1. Charach A, Dashti B, Carson P, et al. Attention deficit hyperactivity disorder: effectiveness of treatment in at-risk preschoolers; long-term effectiveness in all ages; and variability in prevalence, diagnosis, and treatment. Comparative effectiveness review: AHRQ 2011;44. - PubMed